TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch
Bank of America analyst Alec Stranahan raised his price target on TG Therapeutics to $20 from $17 but kept an ‘Underperform’ rating on the shares.
Read the full articleYou might also wanna read
Alnylam price target raised to $468 from $420 at Raymond James
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Robinhood stock slides even as Morgan Stanley lifts target to $124
Morgan Stanley and Barclays have raised their Robinhood price targets to $124 and $122, respectively, even as HOOD has fallen more than 5% t
TPG price target lowered by $7 at Citizens, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Barclays analyst adjusts AMD price target, sees AI workload shift benefiting the chipmaker
The AI trade has spent two years being almost entirely about GPUs.
miramarflnews.com·1mo agoTimken price target raised by $14 at Goldman Sachs
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
General Dynamics price target raised by $40 at Jefferies, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Comments
Sign in to join the conversation.
No comments yet. Be the first.